Showing results (81-90 of 141) with videos related to
Sort By:
Pageof 15
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 3, 2020
p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patternsEmily F Thompson, Julia Chen, Jutta Huvila, et al.The Lancet. Oncology|August 25, 2011
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised studyKaren A Gelmon, Marc Tischkowitz, Helen Mackay, et al.International Journal of Cancer|September 5, 2002
CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancerPaul D P Pharoah, Carla Oliveira, José Carlos Machado, et al.Journal of Medical Genetics|February 19, 2020
Redefinition of familial intestinal gastric cancer: clinical and genetic perspectivesJoana Carvalho, Patricia Oliveira, Janine Senz, et al.Plos One|April 27, 2018
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practiceLeah M Prentice, Ruth R Miller, Jeff Knaggs, et al.Gynecologic Oncology|November 6, 2025
Quantifying opportunities to reduce high grade serous ovarian cancer via opportunistic salpingectomyKristin M Tischer, Nadia S Islam, Michaela E McGree, et al.Cancer Letters|April 14, 2015
Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673Alexandra-Zoe Andrei, Anita Hall, Alyssa L Smith, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapyMark S Carey, Roshan Agarwal, Blake Gilks, et al.Human Molecular Genetics|July 4, 2012
Transcription initiation arising from E-cadherin/CDH1 intron2: a novel protein isoform that increases gastric cancer cell invasion and angiogenesisHugo Pinheiro, Joana Carvalho, Patrícia Oliveira, et al.Hereditary Cancer in Clinical Practice|March 18, 2010
Genetic screening for familial gastric cancerCarla Oliveira, Gianpaolo Suriano, Paulo Ferreira, et al.Pageof 15